MYNEPHRON ME185 Pill — BLACK CAPSULE, 18mm — Folic Acid

No photo available
View full Folic Acid profile
ImprintMYNEPHRON / ME185
ColourBLACK
ShapeCAPSULE
Size18
StrengthASCORBIC ACID 100 mg;FOLIC ACID 1 mg;NIACIN 20 mg;THIAMINE 1.5 mg;RIBOFLAVIN 1.7 mg;PYRIDOXINE 10 mg;CYANOCOBALAMIN 6 ug;PANTOTHENIC ACID 5 mg;BIOTIN 150 ug
Dosage formCapsule
ManufacturerMartin Ekwealor Pharmaceu
NDC58607-185
Schedule—
Availability—
IngredientsASCORBIC ACID[ASCORBIC ACID];FOLIC ACID[FOLIC ACID];NIACIN[NIACIN];THIAMINE[THIAMINE ION];RIBOFLAVIN[RIBOFLAVIN];PYRIDOXINE[PYRIDOXINE];CYANOCOBALAMIN[CYANOCOBALAMIN];PANTOTHENIC ACID[PANTOTHENIC ACID];BIOTIN[BIOTIN]

What does this imprint mean?

The imprint "MYNEPHRON ME185" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Folic Acid

Uses and warnings

No boxed warning. Key warning: "administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient" - doses above 0.1 mg daily may correct the blood picture while neurologic damage from B12 deficiency continues to progress, so B12 deficiency must be excluded before treating with folic acid alone. The label also notes folic acid may antagonize phenytoin's anticonvulsant action.

Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Folic Acid

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file f7c4547b-8ed1-47d0-a53b-664596953446.xml